How Much Funding Have You Raised Since Ipo?

iad learned at agios, where we can sit with patients and end regulators and say, how do we get thi to patients as quickly as we can? That's all incredible. The downsight is it is very capital intensive. It just takes a lot of people. It takes big facilities. Manufacturing is challenging. And so you know from day one we would need a lot of access to capital to do this right. We've really held off doing that, preferring to fund e company with cat with equity for now, and then later,. You know, never cind the phase now, where we have a better idea of what are we doing and what are we not doing.